Julian Harrison
Stock Analyst at BTIG
(4.06)
# 512
Out of 5,041 analysts
57
Total ratings
62%
Success rate
10.47%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Julian Harrison
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLYM Climb Bio | Reiterates: Buy | $8 | $1.99 | +302.01% | 3 | Oct 16, 2025 | |
| TVRD Tvardi Therapeutics | Maintains: Buy | $55 → $15 | $4.97 | +201.81% | 1 | Oct 13, 2025 | |
| APGE Apogee Therapeutics | Reiterates: Buy | $115 | $53.32 | +115.68% | 2 | Oct 9, 2025 | |
| JBIO Jade Biosciences | Initiates: Buy | $28 | $10.00 | +180.00% | 1 | Oct 9, 2025 | |
| ABVX ABIVAX Société Anonyme | Maintains: Buy | $112 → $120 | $90.76 | +32.22% | 3 | Oct 7, 2025 | |
| MLTX MoonLake Immunotherapeutics | Downgrades: Neutral | $85 | $9.52 | +792.86% | 2 | Sep 29, 2025 | |
| ORKA Oruka Therapeutics | Reiterates: Buy | $56 | $27.22 | +105.73% | 2 | Sep 29, 2025 | |
| AVTX Avalo Therapeutics | Reiterates: Buy | $40 | $17.57 | +127.66% | 2 | Sep 29, 2025 | |
| NKTR Nektar Therapeutics | Reiterates: Buy | $100 | $60.10 | +66.39% | 1 | Sep 19, 2025 | |
| RZLT Rezolute | Reiterates: Buy | $17 | $9.19 | +84.98% | 3 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $23.37 | +199.53% | 3 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $37 | $30.39 | +21.75% | 3 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $32 | $7.76 | +312.37% | 1 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $25 | $14.25 | +75.44% | 2 | Jun 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $9.16 | +358.52% | 1 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $15.04 | - | 3 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $35.07 | - | 2 | Dec 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $9 | $1.39 | +547.48% | 5 | Nov 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $8 | $2.15 | +272.09% | 4 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8 | $0.37 | +2,043.05% | 1 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $56 → $61 | $22.16 | +175.27% | 3 | Sep 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $29 → $25 | $22.38 | +11.71% | 3 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $51 | $74.86 | -31.87% | 2 | Jul 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $4 | $3.03 | +32.01% | 1 | Nov 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $150 | $1.60 | +9,275.00% | 1 | Oct 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $418.58 | - | 2 | Feb 11, 2022 |
Climb Bio
Oct 16, 2025
Reiterates: Buy
Price Target: $8
Current: $1.99
Upside: +302.01%
Tvardi Therapeutics
Oct 13, 2025
Maintains: Buy
Price Target: $55 → $15
Current: $4.97
Upside: +201.81%
Apogee Therapeutics
Oct 9, 2025
Reiterates: Buy
Price Target: $115
Current: $53.32
Upside: +115.68%
Jade Biosciences
Oct 9, 2025
Initiates: Buy
Price Target: $28
Current: $10.00
Upside: +180.00%
ABIVAX Société Anonyme
Oct 7, 2025
Maintains: Buy
Price Target: $112 → $120
Current: $90.76
Upside: +32.22%
MoonLake Immunotherapeutics
Sep 29, 2025
Downgrades: Neutral
Price Target: $85
Current: $9.52
Upside: +792.86%
Oruka Therapeutics
Sep 29, 2025
Reiterates: Buy
Price Target: $56
Current: $27.22
Upside: +105.73%
Avalo Therapeutics
Sep 29, 2025
Reiterates: Buy
Price Target: $40
Current: $17.57
Upside: +127.66%
Nektar Therapeutics
Sep 19, 2025
Reiterates: Buy
Price Target: $100
Current: $60.10
Upside: +66.39%
Rezolute
Sep 18, 2025
Reiterates: Buy
Price Target: $17
Current: $9.19
Upside: +84.98%
Sep 16, 2025
Reiterates: Buy
Price Target: $70
Current: $23.37
Upside: +199.53%
Sep 12, 2025
Maintains: Buy
Price Target: $30 → $37
Current: $30.39
Upside: +21.75%
Sep 10, 2025
Reiterates: Buy
Price Target: $32
Current: $7.76
Upside: +312.37%
Jun 27, 2025
Maintains: Buy
Price Target: $24 → $25
Current: $14.25
Upside: +75.44%
Dec 19, 2024
Initiates: Buy
Price Target: $42
Current: $9.16
Upside: +358.52%
Dec 12, 2024
Downgrades: Neutral
Price Target: n/a
Current: $15.04
Upside: -
Dec 2, 2024
Downgrades: Neutral
Price Target: n/a
Current: $35.07
Upside: -
Nov 29, 2024
Maintains: Buy
Price Target: $50 → $9
Current: $1.39
Upside: +547.48%
Nov 19, 2024
Upgrades: Buy
Price Target: $8
Current: $2.15
Upside: +272.09%
Nov 18, 2024
Initiates: Buy
Price Target: $8
Current: $0.37
Upside: +2,043.05%
Sep 26, 2024
Maintains: Buy
Price Target: $56 → $61
Current: $22.16
Upside: +175.27%
Aug 20, 2024
Maintains: Buy
Price Target: $29 → $25
Current: $22.38
Upside: +11.71%
Jul 24, 2024
Maintains: Buy
Price Target: $41 → $51
Current: $74.86
Upside: -31.87%
Nov 29, 2023
Assumes: Buy
Price Target: $4
Current: $3.03
Upside: +32.01%
Oct 11, 2023
Reinstates: Buy
Price Target: $150
Current: $1.60
Upside: +9,275.00%
Feb 11, 2022
Initiates: Neutral
Price Target: n/a
Current: $418.58
Upside: -